Former SEC Chairman Predicts ‘Fair Amount’ of Crypto Regulation

Former SEC Chairman Harvey Pitt says the rules surrounding cryptocurrencies are unclear and expects the SEC to move forward with “clear rules of the road.” He also reacts to the implosion of Archegos. Watch or read a portion of his interview with Bloomberg below.

 

Host: As I say, there’s a lot on his plate. But let’s start with one right off the bat, because this week we saw Coinbase go public. It’s been a lot of talk about SEC having a possible role in regulating, if not cryptocurrency, at least cryptocurrency exchanges. What do you expect to happen?

Pitt: I expect to see a fair amount of regulation of cryptocurrency. Right now I think the rules are unclear. I think whether or not certain offerings involve securities are  unclear. And there’s a definite likelihood that the SEC will move forward. Gary Gensler is an expert on cryptocurrency. He’s taught about them when the market expert and I would expect to see clear rules of the road evolve under his leadership.

Host: So is it clear that the jurisdiction should lie with the SEC? I mean, there’s some questions about is it a security or not? Whatever whatever cryptocurrency we’re talking about. Is it clear it should be SEC. Or Gary Gensler’s old shop of the CFTC?

Pitt: There’s a real question about where jurisdiction lies and there may be a need for clarifying legislation. The FCC has already taken the position that Bitcoin and the theory are not securities and therefore there is no regulatory involvement on the SEC’s part. When you get a company like Coinbase, which is effectively making markets and cryptocurrency and it registers, then that makes the company subject to SEC regulations. And indirectly, the SEC will have an effect on how these cryptocurrencies are marketed.

Host: Let’s talk about another area that I think will get some scrutiny. And that is what we saw with Archegos in a family office and what happened there with the hedge fund dealings I read in the financial times, I’ll reveal my source here that, in fact, there were regulations pending in the SEC that haven’t been finalized yet that would have made it clear to the Credit Suisse’s of this world, the new rules of the world, exactly how much exposure there might be from other banks who had made similar loans.

Pitt: I think there’s been a real problem identified with the whole Archegos situation. First, you had somebody who pled guilty to a felony and insider trading and the family office rules were never intended to effectively allow that person to get back into the securities industry. So I think that’s one issue. I think another issue is the lack of due diligence done by the banks. There are real questions about how diligent they were or whether they were going after the trading profits, because you have multiple banks funding the same transactions and not uncovering that Archegos over leveraged the situation. And that is part of the reason why the losses have been so monumental.

*Bloomberg contributed to this content

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

 

Follow us on social media for the latest updates in B2B!

Image

Latest

pcp
PCP Attribution Analysis
May 22, 2025

Dr. Sam Ambewadikar, RVP and Medical Director at Anthem National Accounts, joins Brent to unpack the power of primary care attribution analysis—a tool he helped pioneer to spotlight the clinical and financial impact of members not having an established PCP. Drawing from his background as a practicing pediatrician and claims analytics leader, Dr. Sam shares…

Read More
sydney health
Sydney Health Demo
May 22, 2025

In this episode, Christina Firouztash, Executive Advisor of Digital Solutions at Anthem, gives a dynamic walkthrough of the Sydney Health app—Anthem’s flagship digital member experience. Christina showcases how Sydney delivers personalized, simple, and equitable navigation across benefits, including virtual care, pharmacy, financial transparency, and social services access. From contextual chatbots and ID card access to…

Read More
pharmacy
Pharmacy Part 1
May 22, 2025

In this episode, Brent chats with Katie Brennan, National Sales Director at CarelonRx, about making pharmacy benefits more accessible, consistent, and member-friendly. Katie spotlights Carelon new advanced home delivery model, which brings the pharmacy counter—and the pharmacist—into the member’s home. With fewer retail pharmacies offering extended hours and many patients lacking reliable transportation, CarelonRx is…

Read More
inclusive care
Inclusive Care
May 22, 2025

Sammy Gonzalez, Regional Vice President at Elevance Health, joins Brent for a deeply personal and impactful conversation on health equity and inclusive care. Sammy shares a powerful story of medical misdiagnosis tied to cultural assumptions, underscoring how bias—even unintentional—can hinder care quality. He highlights Elevance’s work to improve diversity in provider networks, enhance cultural competency,…

Read More